A. Makris

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy

S. Loibl, Miguel Martín, H. Bonnefoi et al. · Annals of Oncology · 2025 · 18 citations

Medicine, Oncology, Pharmacology +17

Abstract OT1-03-12: MANTA: A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer

P. Schmid, Maria do Céu Ferreira, Suparna Dubey et al. · Cancer Research · 2016 · 13 citations

Medicine, Oncology, Pharmacology +17

1069: Once Weekly Tamoxifen in the Prevention of Gynaaecomastia and Breast Pain Secondary to Bicalutamide Therapy

Alan C. Eaton, A. Makris · The Journal of Urology · 2004 · 13 citations

Medicine, Gynecology, Oncology +9

Abstract GS2-07: MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer

P. Schmid, Catherine Harper‐Wynne, Maria do Céu Ferreira et al. · Cancer Research · 2018 · 13 citations

Medicine, Oncology, Pharmacology +17